Related Experiment Video
Updated: Sep 18, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
miR-140-5p Ameliorates Atrial Fibrillation in Cardiomyocytes by Targeting the Water Channel Protein Aquaporin 4
Bokyeong Park1,2, Young Hoon Son3, Sung Jin Park3
1Department of Molecular Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Background And Objectives:
MicroRNAs (miRNAs) are small, non-coding RNAs that control gene expression patterns by inducing the degradation of messenger RNAs (mRNAs). Furthermore, miRNAs are known to play an important role in the pathogenesis of atrial fibrillation (AF). AF is typically diagnosed using an electrocardiogram. However, this study investigated whether specific miRNAs could be involved in alleviating AF by regulating aquaporin 4 (AQP4).
Methods:
HL-1 cells were transfected with either miRNA negative control (NC) or miR-140-5p, followed by incubation with or without tachypacing (TP) condition. We investigated the protein expression of calcium-handling and inflammation-related proteins in control, control + miR-NC, control + miR-140-5p, TP, and TP + miR-140-5p groups by Western blotting. Also, the relative mRNA expression of AQP4 was determined through real-time polymerase chain reaction.
Results:
Compared to the control, miR-140-3p was increased in the TP-induced AF group. Additionally, AQP4 protein expression and mRNA level were increased in the AF group along with inflammation-related proteins toll-like receptor 4, nucleotide-binding domain-like receptor protein 3, ERK, AKT, and interleukin-1β. The increase in such proteins was mitigated through miR-140-5p treatment. In accordance with these results, calcium-handling protein markers CaMKII, phospholamban, and ryanodine receptor 2 gene were also increased in the AF group and alleviated with miR-140-5p treatment.
Conclusions:
miR-140-5p is engaged in suppressing the expression of AQP4 in TP-induced AF HL-1 cells. In doing so, miR-140-5p reduced the risk of AF by suppressing inflammation and phosphorylation of Ca-handling proteins.
Insights
MicroRNA-140-5p (miR-140-5p) suppresses aquaporin 4 (AQP4) expression, reducing inflammation and calcium-handling protein phosphorylation. This finding suggests miR-140-5p may alleviate atrial fibrillation (AF) by targeting AQP4.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Gene Regulation
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in atrial fibrillation (AF) pathogenesis.
- Aquaporin 4 (AQP4) is a water channel protein potentially involved in AF.
- This study explores the role of specific miRNAs in regulating AQP4 and mitigating AF.
Purpose of the Study:
- To investigate the role of miR-140-5p in regulating AQP4 expression.
- To determine if miR-140-5p can alleviate inflammation and calcium-handling protein abnormalities in a cellular model of AF.
- To assess the potential of miR-140-5p as a therapeutic target for AF.
Main Methods:
- HL-1 cells were transfected with miR-140-5p or a control miRNA.
- Cells were subjected to tachypacing (TP) to induce an AF-like state.
- Protein and mRNA expression of AQP4, inflammation markers, and calcium-handling proteins were analyzed using Western blotting and real-time PCR.
Main Results:
- Tachypacing increased miR-140-3p, AQP4, and inflammation markers (TLR4, NLRP3, ERK, AKT, IL-1β).
- miR-140-5p treatment mitigated the TP-induced increases in AQP4 and inflammation markers.
- miR-140-5p also reduced the expression of calcium-handling proteins (CaMKII, phospholamban, RyR2) in TP-induced AF cells.
Conclusions:
- miR-140-5p suppresses AQP4 expression in a cellular model of AF.
- This suppression alleviates inflammation and abnormal phosphorylation of calcium-handling proteins.
- miR-140-5p demonstrates potential as a therapeutic agent for reducing AF risk.
More Related Videos
10:53Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Related Concept Videos
Aquaporins
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System